menu
    • menu

    Company profile for Avalyn Pharma

    NEW Drugs in Dev: 3
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Avalyn is a biopharma company committed to developing improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. Our lead asset is inhaled pirfenidone (AP01) for the treatment of IPF. With offices in Seattle and San Diego, Avalyn's experienced clinical and inhaled product development team is rapidly advancing AP01 for the treatment of IPF and additional pipeline candidate...
    Avalyn is a biopharma company committed to developing improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. Our lead asset is inhaled pirfenidone (AP01) for the treatment of IPF. With offices in Seattle and San Diego, Avalyn's experienced clinical and inhaled product development team is rapidly advancing AP01 for the treatment of IPF and additional pipeline candidates for IPF and other severe respiratory diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Avalyn PharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    701 Pike Street Suite 1500 Seattle, WA 98101
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.avalynpharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Avalyn Reports Q1 2026 Financial Results and Business Highlights
    Avalyn Reports Q1 2026 Financial Results and Business Highlights

    03 Jun 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/06/03/3305895/0/en/avalyn-reports-first-quarter-2026-financial-results-and-recent-business-highlights.html

    GLOBENEWSWIRE
    03 Jun 2026
    Share Share
    Avalyn to Present at Jefferies Global Healthcare Conference
    Avalyn to Present at Jefferies Global Healthcare Conference

    27 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/27/3301859/0/en/avalyn-to-participate-in-the-jefferies-global-healthcare-conference.html

    GLOBENEWSWIRE
    27 May 2026
    Share Share
    Avalyn to Present AP01 Pulmonary Fibrosis Data at EULAR 2026
    Avalyn to Present AP01 Pulmonary Fibrosis Data at EULAR 2026

    21 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/21/3299268/0/en/avalyn-announces-additional-long-term-data-on-ap01-inhaled-pirfenidone-for-the-treatment-of-pulmonary-fibrosis-to-be-presented-at-the-european-alliance-of-associations-for-rheumato.html

    GLOBENEWSWIRE
    21 May 2026
    Share Share
    Avalyn to Present AP01 Research at ATS 2026
    Avalyn to Present AP01 Research at ATS 2026

    05 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/05/3288206/0/en/avalyn-to-present-patient-centered-research-on-ap01-delivery-and-supportive-care-experiences-at-american-thoracic-society-2026-international-conference.html

    GLOBENEWSWIRE
    05 May 2026
    Share Share
    Avalyn Closes Ipo With Full Underwriters' Share Purchase Exercise
    Avalyn Closes Ipo With Full Underwriters' Share Purchase Exercise

    01 May 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7259578

    FIRSTWORD PHARMA
    01 May 2026
    Share Share
    Novo-Backed Drugmaker Avalyn Soars 44% After $300 Million US IPO
    Novo-Backed Drugmaker Avalyn Soars 44% After $300 Million US IPO

    30 Apr 2026

    // BLOOMBERG

    https://www.bloomberg.com/news/articles/2026-04-30/novo-backed-drugmaker-avalyn-soars-44-after-300-million-us-ipo

    BLOOMBERG
    30 Apr 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search